))
ADHD Medications: Risk, Bias, and Real Outcomes
Manage episode 493636461 series 3676728
Inhalt bereitgestellt von James Kennedy, PMHNP-BC & Jon Murphy, PMHNP-BC and Compass Point Institute. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von James Kennedy, PMHNP-BC & Jon Murphy, PMHNP-BC and Compass Point Institute oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
Title: ADHD Medications: Risk, Bias, and Real Outcomes
Hosts: James Kennedy, PMHNP-BC & Jon Murphy, PMHNP-BC
In this first episode of Compass Point Institute, James and Jon break down a major new study published in JAMA Psychiatry (June 25, 2025) tracking ADHD medication outcomes in over 260,000 individuals.
🎯 Topics covered:
- Key findings from a 15-year longitudinal study
- Reduced self-harm, accident, and criminal risk
- Navigating stigma, DEA scrutiny, and Schedule II status
- Provider bias and the myth of “weekend breaks”
- Practical clinical guidance on stimulant prescribing
- The difference between physiological vs psychological addiction
This episode is designed to support mental health clinicians with real-world data, clear context, and grounded insight.
📬 Have a topic you want us to cover? Reach out anytime.
🧭 Compass Point Institute — Empowering the next generation of mental health clinicians.
7 Episoden
Teilen
